WallStSmart
ARCT

Arcturus Therapeutics Holdings Inc

NASDAQ: ARCT · HEALTHCARE · BIOTECHNOLOGY

$8.40
-5.30% today

Updated 2026-04-29

Market cap
$238.75M
P/E ratio
P/S ratio
2.91x
EPS (TTM)
$-2.40
Dividend yield
52W range
$6 – $24
Volume
0.5M

Arcturus Therapeutics Holdings Inc (ARCT) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item20112012201320142015201620172018201920202021202220232024
Total assets$1.20M$201000.00$50.32M$22.32M$71.68M$51.57M$52.02M$44.20M$82.14M$476.46M$392.81M$450.39M$429.40M$344.07M
Cash & equivalents$55000.00$97000.00$22.09M$2.18M$16.66M$2.30M$24.96M$36.71M$71.35M$462.89M$370.49M$391.88M$292.00M$237.03M
Current assets$667000.00$180000.00$50.22M$22.13M$52.35M$51.30M$50.87M$41.83M$74.29M$467.79M$378.96M$403.33M$386.59M$305.98M
Total liabilities$219000.00$768000.00$1.64M$2.38M$2.35M$4.34M$18.23M$30.56M$56.35M$79.90M$164.60M$180.07M$150.89M$103.09M
Current liabilities$219000.00$768000.00$1.64M$2.38M$2.35M$4.34M$11.04M$12.58M$21.32M$49.52M$99.54M$126.98M$81.99M$65.49M
Long-term debt$9.91M$14.99M$13.85M$40.63M
Shareholder equity$985000.00$-567000.00$48.69M$19.94M$69.33M$47.23M$33.79M$13.64M$25.79M$396.55M$228.21M$270.31M$278.51M$240.98M
Retained earnings$-6.61M$-8.19M$-18.73M$-51.57M$-71.02M$-95.62M$-23.09M$-44.87M$-71.67M$-143.82M$-347.49M$-338.14M$-367.87M$-448.81M
Accounts receivable$93000.00$10000.00$46000.00$117000.00$328000.00$3.63M$480000.00$4.48M$2.18M$2.13M$3.37M$2.76M$32.06M$3.97M
Inventory$-46000.00$-116000.00$-521000.00$1.46M$1.00$1.00$-7.52M
Goodwill